AURO-RAMIPRIL CAPS 1.25 ramipril 1.25 mg capsule blister pack

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

ramipril, Quantity: 1.25 mg

Verfügbar ab:

Arrotex Pharmaceuticals Pty Ltd

INN (Internationale Bezeichnung):

Ramipril

Darreichungsform:

Capsule

Zusammensetzung:

Excipient Ingredients: pregelatinised maize starch; hydrophobic colloidal silica anhydrous; titanium dioxide; purified water; iron oxide yellow; Gelatin; sodium lauryl sulfate

Verabreichungsweg:

Oral

Einheiten im Paket:

30, 28

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

? Treatment of hypertension. Data are currently not available to support the use of ramipril in renovascular hypertension. ,? Post MI heart failure ,? Prevention of progressive renal failure in patients with persistent proteinuria in excess of 1 g/day. ,? For reducing the risk of myocardial infarction, stroke, cardiovascular death or the need for revascularisation procedures in patients 55 years of age or more who have clinical evidence of coronary artery disease, stroke, or peripheral vascular disease. ,? For reducing the risk of myocardial infarction, stroke, cardiovascular death or revascularisation procedures in diabetic patients 55 years or more with one or more of the following risk factors: systolic blood pressure >160mmHg or diastolic blood pressure >90mmHg (or on antihypertensive treatment); total cholesterol >5.2mmol/L; HDL cholesterol <0.9mmol/L; current smoker; known microalbuminuria; any evidence of previous vascular disease.

Produktbesonderheiten:

Visual Identification: Yellow/White size 4 hard capsules imprinted with D on yellow cap & 40 on white body with black edible ink filled with white to almost white powder; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2013-08-14